Current Treatment Insights

Connect with Expert

Treatment landscape analysis insight report describes the current treatment and management of a specific disease area. The analysis includes various current approved and off-label therapies, their respective doses, durations, efficacy, and safety benchmarks. The use of treatments by a line of therapy, including their KOL-perceived advantages and disadvantages, are studied. In addition, an in-depth assessment of patient characteristics, diagnosis, comorbidities, and their treatment, including treatment switches, polypharmacy, compliance, and persistence, is conducted.

Key outcomes:

  • What are the currently available therapies for the specific disease area in the G8 markets (US, EU5, Japan, China)?
  • What are the patient shares for current therapies in various lines of treatment?
  • What key factors influence physicians to prescribe brands for managing the condition?
  • What are the obstacles preventing physicians from using brands for managing the condition?
  • How do physician practices align or differ from the treatment guidelines?
  • What are KOL expectations from emerging therapies to overcome the challenges of current therapies?

Reports:

October 31, 2024

Market Outlook and Forecast

Iron Deficiency Anemia (IDA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Iron Deficiency Anemia (IDA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Iron Deficiency Anemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 16, 2024

Market Outlook and Forecast

Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Pulmonary Hypertension associated with Interstitial Lung Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 22, 2024

Market Outlook and Forecast

Glycogen Storage Disease Type 1a (GSD1a) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Glycogen Storage Disease Type 1a (GSD1a) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Glycogen Storage Disease Type 1a treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 11, 2024

Market Outlook and Forecast

Severe Aplastic Anemia (SAA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Severe Aplastic Anemia (SAA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Severe Aplastic Anemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 27, 2024

Market Outlook and Forecast

Iron Overload Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Iron Overload Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Iron Overload Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 20, 2024

Market Outlook and Forecast

Postoperative Nausea and Vomiting (PONV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Postoperative Nausea and Vomiting (PONV) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Postoperative Nausea and Vomiting treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Explore Reports

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Connect with Expert